116 related articles for article (PubMed ID: 8894106)
1. Properties of analogues of an intermediate in the process of mechanism-based inactivation of carboxypeptidase A.
Ghosh SS; Dakoji S; Tanaka Y; Cho YJ; Mobashery S
Bioorg Med Chem; 1996 Sep; 4(9):1487-92. PubMed ID: 8894106
[TBL] [Abstract][Full Text] [Related]
2. Peptidic mechanism-based inactivators for carboxypeptidase A.
Ghosh SS; Wu YQ; Mobashery S
J Biol Chem; 1991 May; 266(14):8759-64. PubMed ID: 2026592
[TBL] [Abstract][Full Text] [Related]
3. Design of mechanism-based carboxypeptidase A inactivators on the basis of the X-ray crystal structure and catalytic reaction pathway.
Lee KJ; Kim DH
Bioorg Med Chem; 1998 Sep; 6(9):1613-22. PubMed ID: 9801832
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic insight into the inactivation of carboxypeptidase A by alpha-benzyl-2-oxo-1,3-oxazolidine-4-acetic acid, a novel type of irreversible inhibitor for carboxypeptidase A with no stereospecificity.
Chung SJ; Chung S; Lee HS; Kim EJ; Oh KS; Choi HS; Kim KS; Kim YJ; Hahn JH; Kim DH
J Org Chem; 2001 Sep; 66(19):6462-71. PubMed ID: 11559199
[TBL] [Abstract][Full Text] [Related]
5. The role of Tyr248 probed by mutant bovine carboxypeptidase A: insight into the catalytic mechanism of carboxypeptidase A.
Cho JH; Kim DH; Lee KJ; Kim DH; Choi KY
Biochemistry; 2001 Aug; 40(34):10197-203. PubMed ID: 11513597
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the structures of three carboxypeptidase A-phosphonate complexes determined by X-ray crystallography.
Kim H; Lipscomb WN
Biochemistry; 1991 Aug; 30(33):8171-80. PubMed ID: 1868092
[TBL] [Abstract][Full Text] [Related]
7. Insight into the stereochemistry in the inhibition of carboxypeptidase A with N-(hydroxyaminocarbonyl)phenylalanine: binding modes of an enantiomeric pair of the inhibitor to carboxypeptidase A.
Cho JH; Kim DH; Chung SJ; Ha NC; Oh BH; Yong Choi K
Bioorg Med Chem; 2002 Jun; 10(6):2015-22. PubMed ID: 11937361
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of carboxypeptidase A complexed with an inactivator in two crystal forms.
Chai JJ; He C; Li M; Tang L; Luo M
Protein Eng; 1998 Oct; 11(10):841-5. PubMed ID: 9862201
[TBL] [Abstract][Full Text] [Related]
9. Design of an effective mechanism-based inactivator for a zinc protease.
Mobashery S; Ghosh SS; Tamura SY; Kaiser ET
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):578-82. PubMed ID: 2300547
[TBL] [Abstract][Full Text] [Related]
10. A thioamide substrate of carboxypeptidase A.
Bartlett PA; Spear KL; Jacobsen NE
Biochemistry; 1982 Mar; 21(7):1608-11. PubMed ID: 7082637
[TBL] [Abstract][Full Text] [Related]
11. Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases.
Park JD; Kim DH; Kim SJ; Woo JR; Ryu SE
J Med Chem; 2002 Nov; 45(24):5295-302. PubMed ID: 12431056
[TBL] [Abstract][Full Text] [Related]
12. Direct chemical evidence for the mixed anhydride intermediate of carboxypeptidase A in ester and peptide hydrolysis.
Sander ME; Witzel H
Biochem Biophys Res Commun; 1985 Oct; 132(2):681-7. PubMed ID: 4062944
[TBL] [Abstract][Full Text] [Related]
13. Interaction of carboxypeptidase A with carbamate and carbonate esters.
King SW; Lum VR; Fife TH
Biochemistry; 1987 Apr; 26(8):2294-300. PubMed ID: 3620447
[TBL] [Abstract][Full Text] [Related]
14. Kinetic study of carboxypeptidase P-catalyzed reaction. Pressure and temperature dependence of kinetic parameters.
Fukuda M; Shima H; Kunugi S
J Biochem; 1985 Aug; 98(2):517-25. PubMed ID: 4066652
[TBL] [Abstract][Full Text] [Related]
15. Chemistry-based design of inhibitors for carboxypeptidase A.
Kim DH
Curr Top Med Chem; 2004; 4(12):1217-26. PubMed ID: 15320722
[TBL] [Abstract][Full Text] [Related]
16. Hippuryl-alpha-methylphenylalanine and hippuryl-alpha-methylphenyllactic acid as substrates for carboxypeptidase A. Syntheses, kinetic evaluation and mechanistic implication.
Lee M; Kim DH
Bioorg Med Chem; 2000 Apr; 8(4):815-23. PubMed ID: 10819170
[TBL] [Abstract][Full Text] [Related]
17. Effect of D2O on the carboxypeptidase-catalyzed hydrolysis of O-(trans-cinnamoyl)-L-beta-phenyllactate and N-(N-benzoylglycyl)-L-phenylalanine.
Kaiser BL; Kaiser ET
Proc Natl Acad Sci U S A; 1969 Sep; 64(1):36-41. PubMed ID: 5263018
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the complex of carboxypeptidase A with a strongly bound phosphonate in a new crystalline form: comparison with structures of other complexes.
Kim H; Lipscomb WN
Biochemistry; 1990 Jun; 29(23):5546-55. PubMed ID: 2386784
[TBL] [Abstract][Full Text] [Related]
19. Catalytic conformation of carboxypeptidase A. Structure of a true enzyme reaction intermediate determined by electron nuclear double resonance.
Mustafi D; Makinen MW
J Biol Chem; 1994 Feb; 269(6):4587-95. PubMed ID: 8308030
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical property modification strategies based on enzyme substrate specificities III: carboxypeptidase A hydrolysis of aspirin derivatives.
Banerjee PK; Amidon GL
J Pharm Sci; 1981 Dec; 70(12):1307-9. PubMed ID: 7320841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
